Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study

Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study

BADBIR Study Group, the BSTOP Study Group, the PSORT Consortium, Pan, S., Tsakok, T., Dand, N., Lonsdale, D. O., Loeff, F. C., Bloem, K., de Vries, A., Baudry, D., Duckworth, M., Mahil, S., Pushpa-Rajah, A., Russell, A., Alsharqi, A., Becher, G., Murphy, R., Wahie, S., Wright, A., Griffiths, C. E. M. & Reynolds, N. J. & 6 others, Barker, J., Warren, R. B., David Burden, A., Rispens, T., Standing, J. F. & Smith, C. H., 1 Mar 2020, In: Clinical and Translational Science. 13, 2, p. 400-409 10 p.

Research output: Contribution to journal › Article › peer-review